BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target RIPK1

Receptor-interacting serine/threonine-protein kinase 1 · 21 compounds in BiohacksAI corpus

RIPK1 (Receptor-interacting serine/threonine-protein kinase 1) is a biological target with 21 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into RIPK1 modulation for therapeutic and biohacking applications.

All 21 Compounds — Ranked by Evidence
1
Foretinib
4.34
confidence
2
Tozasertib
4.33
confidence
3
Ponatinib
4.26
confidence
4
Quizartinib
3.99
confidence
5
Pazopanib
3.69
confidence
6
Nintedanib
3.61
confidence
7
Fedratinib
3.40
confidence
8
Linifanib
3.33
confidence
9
Fexagratinib
3.33
confidence
10
Dabrafenib
3.30
confidence
11
Necrostatin
3.30
confidence
12
Dovitinib
3.09
confidence
13
Jnj 7706621
3.09
confidence
14
Pha 665752
2.71
confidence
15
Plx 4720
2.71
confidence
16
Kw 2449
2.64
confidence
17
Ast 487
2.56
confidence
18
Raf 265
2.48
confidence
19
Su 014813
2.20
confidence
20
Rebastinib
2.20
confidence
21
Gw770249x
1.79
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for RIPK1 (Receptor-interacting serine/threonine-protein kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: RIPK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.